| abstract |
A readily absorbable motilin preparation contains a motilin-like active substance and a surface active agent. The preferred active substance is L-leucine-13-motilin-homoserine, and the surface active agent is selected from bile salts, saponins and polyethylene glycol higher-alcohol ethers for preparations for nasal administration, and is a peptide lytic enzyme inhibitor for preparations for oral administration. |